Raymond James submits Form 144 for CLNE common stock
Raymond James & Associates submitted a Form 144 notice relating to proposed sales of Common stock of CLNE on 05/18/2026 for Nasdaq‑listed shares.
Rhea-AI Filing Summary
Raymond James & Associates submitted a Form 144 notice relating to proposed sales of Common stock of CLNE on 05/18/2026 for Nasdaq‑listed shares. The filing lists historical acquisition events and share counts tied to purchases, RSU vesting, and option exercises including 23,253; 23,840; and 117,907 shares respectively.
Positive
- None.
Negative
- None.
Insights
Filing is a notice of proposed resale under Form 144 listing prior acquisitions and quantities.
The filing lists acquisition methods and specific share counts: 23,253 (open market), 23,840 (RSU vesting), and 117,907 (stock option exercise). It is a compliance disclosure rather than a completed public sale.
Permitted resale timing and methods are governed by Rule 144 conditions; this notice alone does not confirm execution, pricing, or proceeds.
Key Figures
Key Terms
RSU VESTING financial
STOCK OPTION EXERCISE financial
OPEN MARKET PURCHASE financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 from Raymond James for CLNE indicate?
Who is the filing agent and where is it located?
AI-generated analysis. How Rhea-AI works. Not financial advice.